Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat vs Benzbromarone in CKD
NCT02338323Completed
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Jan 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of febuxostat in chronic kidney disease (CKD) and hyperuricemia (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Renal function (eGFR) at 12 months. Started Jan 2015; status: completed.
02
Drugs
febuxostat
03
Conditions
chronic kidney disease (CKD)hyperuricemia
Beyond the preview
Go deeper on NCT02338323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02338323.